1. Home
  2. MDGL vs IDA Comparison

MDGL vs IDA Comparison

Compare MDGL & IDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • IDA
  • Stock Information
  • Founded
  • MDGL 2011
  • IDA 1915
  • Country
  • MDGL United States
  • IDA United States
  • Employees
  • MDGL N/A
  • IDA N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • IDA Electric Utilities: Central
  • Sector
  • MDGL Health Care
  • IDA Utilities
  • Exchange
  • MDGL Nasdaq
  • IDA Nasdaq
  • Market Cap
  • MDGL 6.1B
  • IDA 6.8B
  • IPO Year
  • MDGL N/A
  • IDA N/A
  • Fundamental
  • Price
  • MDGL $421.88
  • IDA $125.61
  • Analyst Decision
  • MDGL Strong Buy
  • IDA Buy
  • Analyst Count
  • MDGL 10
  • IDA 7
  • Target Price
  • MDGL $474.67
  • IDA $122.86
  • AVG Volume (30 Days)
  • MDGL 349.9K
  • IDA 314.3K
  • Earning Date
  • MDGL 10-30-2025
  • IDA 10-30-2025
  • Dividend Yield
  • MDGL N/A
  • IDA 2.74%
  • EPS Growth
  • MDGL N/A
  • IDA 6.48
  • EPS
  • MDGL N/A
  • IDA 5.70
  • Revenue
  • MDGL $515,547,000.00
  • IDA $1,809,996,000.00
  • Revenue This Year
  • MDGL $394.12
  • IDA $5.11
  • Revenue Next Year
  • MDGL $57.74
  • IDA $8.96
  • P/E Ratio
  • MDGL N/A
  • IDA $22.01
  • Revenue Growth
  • MDGL 3421.98
  • IDA N/A
  • 52 Week Low
  • MDGL $200.63
  • IDA $99.81
  • 52 Week High
  • MDGL $457.16
  • IDA $128.50
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 52.53
  • IDA 53.78
  • Support Level
  • MDGL N/A
  • IDA $122.30
  • Resistance Level
  • MDGL $440.90
  • IDA $126.53
  • Average True Range (ATR)
  • MDGL 12.68
  • IDA 1.36
  • MACD
  • MDGL -20.82
  • IDA -6.87
  • Stochastic Oscillator
  • MDGL 92.79
  • IDA 99.31

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About IDA IDACORP Inc.

Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The companys only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which involved in food processing, electronics and general manufacturing, agriculture, health care, government, and education.

Share on Social Networks: